- Home
- SARO vs QGEN Comparison
SARO vs QGEN Comparison
Compare SARO & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SARO
- QGEN
- Stock Information
- Founded
- SARO 1911
- QGEN 1986
- Country
- SARO United States
- QGEN Netherlands
- Employees
- SARO N/A
- QGEN N/A
- Industry
- SARO
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SARO
- QGEN Health Care
- Exchange
- SARO NYSE
- QGEN Nasdaq
- Market Cap
- SARO 8.2B
- QGEN 9.1B
- IPO Year
- SARO 2024
- QGEN 1996
- Fundamental
- Price
- SARO $27.76
- QGEN $41.86
- Analyst Decision
- SARO Buy
- QGEN Buy
- Analyst Count
- SARO 8
- QGEN 8
- Target Price
- SARO $34.50
- QGEN $50.53
- AVG Volume (30 Days)
- SARO 1.5M
- QGEN 1.3M
- Earning Date
- SARO 05-12-2025
- QGEN 05-07-2025
- Dividend Yield
- SARO N/A
- QGEN 3.15%
- EPS Growth
- SARO N/A
- QGEN N/A
- EPS
- SARO 0.04
- QGEN 0.42
- Revenue
- SARO $5,237,161,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- SARO $14.74
- QGEN $4.89
- Revenue Next Year
- SARO $11.20
- QGEN $6.41
- P/E Ratio
- SARO $729.32
- QGEN $100.26
- Revenue Growth
- SARO 14.77
- QGEN 3.31
- 52 Week Low
- SARO $21.31
- QGEN $37.63
- 52 Week High
- SARO $34.38
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- SARO N/A
- QGEN 50.87
- Support Level
- SARO N/A
- QGEN $42.04
- Resistance Level
- SARO N/A
- QGEN $43.46
- Average True Range (ATR)
- SARO 0.00
- QGEN 0.83
- MACD
- SARO 0.00
- QGEN -0.10
- Stochastic Oscillator
- SARO 0.00
- QGEN 17.95
About SARO STANDARDAERO INC.
StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).